| First Author | Saito Y | Year | 2011 |
| Journal | Biochem Biophys Res Commun | Volume | 405 |
| Issue | 2 | Pages | 303-7 |
| PubMed ID | 21219862 | Mgi Jnum | J:168580 |
| Mgi Id | MGI:4889019 | Doi | 10.1016/j.bbrc.2011.01.033 |
| Citation | Saito Y, et al. (2011) A cell-death-defying factor, anamorsin mediates cell growth through inactivation of PKC and p38MAPK. Biochem Biophys Res Commun 405(2):303-7 |
| abstractText | Anamorsin (AM) plays crucial roles in hematopoiesis and embryogenesis. AM deficient (AM KO) mice die during late gestation; AM KO embryos are anemic and very small compared to wild type (WT) embryos. To determine which signaling pathways AM utilizes for these functions, we used murine embryonic fibroblast (MEF) cells generated from E-14.5 AM KO or WT embryos. Proliferation of AM KO MEF cells was markedly retarded, and PKCtheta, PKCdelta, and p38MAPK were more highly phosphorylated in AM KO MEF cells. Expression of cyclinD1, the target molecule of p38MAPK, was down-regulated in AM KO MEF cells. p38MAPK inhibitor as well as PKC inhibitor restored expression of cyclinD1 and cell growth in AM KO MEF cells. These data suggest that PKCtheta, PKCdelta, and p38MAPK activation lead to cell cycle retardation in AM KO MEF cells, and that AM may negatively regulate novel PKCs and p38MAPK in MEF cells. |
